Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group.
Fountzilas E, Koliou GA, Vozikis A, Rapti V, Nikolakopoulos A, Boutis A, Christopoulou A, Kontogiorgos I, Karageorgopoulou S, Lalla E, Tryfonopoulos D, Boukovinas I, Rapti C, Nikolaidi A, Karteri S, Moirogiorgou E, Binas I, Mauri D, Aravantinos G, Zagouri F, Saridaki Z, Psyrri A, Bafaloukos D, Koumarianou A, Res E, Linardou H, Mountzios G, Razis E, Fountzilas G, Koumakis G. Fountzilas E, et al. Among authors: nikolakopoulos a. ESMO Open. 2020 Aug;5(4):e000774. doi: 10.1136/esmoopen-2020-000774. ESMO Open. 2020. PMID: 32817060 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 35643688
Targeted therapies for advanced non-small cell lung cancer.
Starakis I, Nikolakopoulos A, Mazokopakis EE. Starakis I, et al. Among authors: nikolakopoulos a. Comb Chem High Throughput Screen. 2012 Sep;15(8):641-55. doi: 10.2174/138620712802650513. Comb Chem High Throughput Screen. 2012. PMID: 22409867 Review.
PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors.
Dimitrakopoulos FI, Nikolakopoulos A, Kottorou A, Kalofonou F, Liolis E, Frantzi T, Pyrousis I, Koutras A, Makatsoris T, Kalofonos H. Dimitrakopoulos FI, et al. Among authors: nikolakopoulos a. Cancers (Basel). 2020 May 16;12(5):1257. doi: 10.3390/cancers12051257. Cancers (Basel). 2020. PMID: 32429368 Free PMC article.
Seasonal variability in the incidence of carcinomatous meningitis.
Koutras A, Sakellakis M, Makatsoris T, Psachoulia C, Kardari M, Nikolakopoulos A, Gogos C, Kalofonos HP. Koutras A, et al. Among authors: nikolakopoulos a. J Neurosurg. 2015 Mar;122(3):543-6. doi: 10.3171/2014.11.JNS14174. Epub 2015 Jan 9. J Neurosurg. 2015. PMID: 25574572
An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade.
Houbaert D, Nikolakopoulos AP, Jacobs KA, Meçe O, Roels J, Shankar G, Agrawal M, More S, Ganne M, Rillaerts K, Boon L, Swoboda M, Nobis M, Mourao L, Bosisio F, Vandamme N, Bergers G, Scheele CLGJ, Agostinis P. Houbaert D, et al. Among authors: nikolakopoulos ap. Cell Rep. 2024 Apr 23;43(4):114020. doi: 10.1016/j.celrep.2024.114020. Epub 2024 Mar 28. Cell Rep. 2024. PMID: 38554280 Free article.
13 results